title: Limitations of the severe combined immunodeficiency (SCID) mouse model for study of human B-cell responses.
abstract: Mice lacking functional T and B lymphocytes offer an in vivo animal model for the study of human immune functions. We have attempted to optimize the reconstitution of severe combined immunodeficiency (SCID) mice with human peripheral blood lymphocytes (PBL) using radiation, anti-asialo GM1 antibody or cyclophosphamide (Cy) treatment of the mice and in vitro stimulation of human PBL with interleukin (IL)-2 prior to their transfer to the mice. Total human IgG and tetanus-toxoid (TT)-specific human IgG responses of the mice were used as parameters of successful reconstitution. Treatment of the mice with anti-asialo GM1 antibody significantly enhanced total human IgG levels, but not TT-specific antibody responses, whereas irradiation or Cy treatment of the mice had no effect on human antibody production. In vitro treatment of human PBL with IL-2 prior to engraftment significantly decreased total human IgG responses of human PBL-grafted SCID mice. The immune responses of individual mice within a group were highly variable, which constitutes a major disadvantage of this model.
authors.affiliation: Wistar Institute, Philadelphia, PA.
authors.forename: R
authors.initials: R
authors.lastname: Somasundaram
authors.forename: L
authors.initials: L
authors.lastname: Jacob
authors.forename: K
authors.initials: K
authors.lastname: Adachi
authors.forename: R
authors.initials: R
authors.lastname: Class
authors.forename: S
authors.initials: S
authors.lastname: Scheck
authors.forename: H
authors.initials: H
authors.lastname: Maruyama
authors.forename: D
authors.initials: D
authors.lastname: Herlyn
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D003520:Cyclophosphamide / Q000494:pharmacology; D004195:Disease Models, Animal; D005677:G(M1) Ganglioside / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007376:Interleukin-2 / Q000494:pharmacology; D051379:Mice; D016513:Mice, SCID; D011994:Recombinant Proteins / Q000494:pharmacology; D016511:Severe Combined Immunodeficiency / Q000276:immunology*; D013745:Tetanus Toxoid / Q000276:immunology; D014916:Whole-Body Irradiation
chemical_list: D000906:Antibodies; D007074:Immunoglobulin G; D007376:Interleukin-2; D011994:Recombinant Proteins; D013745:Tetanus Toxoid; D005677:G(M1) Ganglioside; C018835:asialo GM1 ganglioside; D003520:Cyclophosphamide